A six-week randomized study involving 40 adults with obesity and fatty liver disease found that artichoke leaf extract was associated with reductions in liver fat, liver size and overall fat mass, though larger and longer trials are needed.
By yourNEWS Media Newsroom
Artichoke leaf extract may help reduce fat stored in the liver and shrink liver volume in people with obesity and fatty liver disease, according to an early clinical trial conducted by researchers at Saarland University in Germany.
The randomized, placebo-controlled study followed 40 patients preparing for bariatric surgery and found measurable improvements among those who received the plant extract during the six weeks before their procedures.
Researchers reported reductions in liver fat, liver size and body fat mass compared with participants given a placebo. Changes in liver fat were detectable within three weeks of supplementation, suggesting that the extract may influence liver metabolism over a relatively short period.
The findings were published in July 2026 in the Journal of Clinical Lipidology.
The study adds to growing interest in artichoke leaf extract as a possible complementary approach for metabolic dysfunction-associated steatotic liver disease, commonly called fatty liver disease. The condition occurs when excessive fat accumulates in liver cells and is frequently associated with obesity, insulin resistance, Type 2 diabetes, elevated blood lipids and other metabolic problems.
Fatty liver disease often produces no clear symptoms during its early stages. Many patients learn they have it only after abnormal liver enzymes appear on routine bloodwork or imaging detects fat accumulation.
Without improvement, some cases can progress to inflammation, scarring, cirrhosis or liver failure. The degree of risk varies, and not everyone with excess liver fat develops advanced disease.
The German investigators studied patients already scheduled for bariatric surgery, a setting in which reducing liver size can have practical importance. An enlarged, fat-filled liver may make abdominal surgery more difficult by limiting a surgeon’s access to the stomach and surrounding structures.
Participants were assigned to receive either artichoke leaf extract or a placebo for six weeks. Researchers then compared changes in liver fat, organ size and body composition.
Liver fat was evaluated using FibroScan, a specialized ultrasound-based technology that measures controlled attenuation parameters. The technique estimates the degree of fat accumulation by assessing how sound waves travel through liver tissue.
Separate ultrasound measurements were used to evaluate liver size. Researchers also monitored body composition to determine whether changes extended beyond the liver.
Patients receiving artichoke leaf extract recorded greater reductions in liver fat than those in the placebo group. Their liver volume also decreased, and investigators reported a decline in total fat mass.
The study’s small size means the results should be interpreted as preliminary. Forty participants are not enough to determine how consistently the extract would perform across broader populations, including people with different ages, body weights, medications, stages of liver disease or underlying health conditions.
The six-week trial also did not establish whether the improvements would continue with longer use, disappear after supplementation stopped or translate into a lower risk of cirrhosis, liver-related complications or cardiovascular disease.
Researchers have studied artichoke leaf for liver and metabolic health before. A 2018 trial involving 100 adults with nonalcoholic fatty liver disease examined 600 milligrams of artichoke leaf extract daily for two months.
That study reported improvements in liver enzymes, cholesterol, bilirubin and ultrasound findings.
Another trial involving people with nonalcoholic steatohepatitis, a more advanced inflammatory form of fatty liver disease, used 2,700 milligrams daily for two months. Participants receiving the extract experienced reductions in liver enzymes and blood lipid levels compared with those receiving a placebo.
The doses used in clinical research have varied substantially, making it difficult to identify one standard amount for all patients. Commercial supplements commonly provide approximately 320 to 640 milligrams per day, often divided and taken with meals, but the appropriate dose can depend on the extract’s concentration and formulation.
Artichoke leaves contain several biologically active plant compounds that may help explain the reported effects.
Cynarin is among the best known. It has been studied for its ability to promote bile production and may influence the digestion and processing of dietary fats.
Bile is produced by the liver and stored in the gallbladder. It helps the digestive system break down fats and absorb fat-soluble vitamins. Increased bile flow may affect cholesterol and fat metabolism, although the exact relationship between that process and reduced liver fat remains under investigation.
Artichoke leaves also contain luteolin, caffeoylquinic acids and other polyphenols with antioxidant and anti-inflammatory properties.
Luteolin may help protect cells from oxidative stress, while caffeoylquinic acids have been studied for their ability to bind or neutralize certain reactive compounds. Laboratory findings involving those substances do not necessarily establish the same effects in patients taking a supplement.
Descriptions of artichoke compounds as “silymarin-like” generally refer to similarities in proposed antioxidant or liver-supporting activity. Silymarin itself is a separate collection of compounds derived from milk thistle and should not be treated as chemically identical to artichoke constituents.
Claims that artichoke “detoxifies” the liver also require precision. The liver naturally processes medications, alcohol, metabolic waste and other substances. Artichoke extract may influence bile flow, antioxidant defenses or lipid metabolism, but clinical trials have not shown that it broadly removes undefined toxins from the body.
The edible artichoke heart supplies fiber, vitamin C, minerals and other nutrients. The leaves contain higher concentrations of several polyphenols used in standardized herbal extracts.
Whole artichokes also provide inulin, a fermentable prebiotic fiber that feeds beneficial intestinal bacteria. Changes in the gut microbiome may affect inflammation and metabolism, although the German study did not establish that inulin or gut bacteria caused the observed liver improvements.
Eating whole artichokes is not equivalent to taking a concentrated leaf extract. The quantity and absorption of active compounds can differ considerably between food and supplements.
Artichoke leaf extract is generally considered well tolerated, but it is not appropriate for everyone.
People with gallstones, bile duct obstruction or other disorders affecting bile flow should consult a healthcare professional before using it. Stimulating bile production or movement could worsen symptoms or create complications when the biliary system is blocked.
Possible adverse effects may include digestive discomfort, gas, nausea, diarrhea or allergic reactions. People sensitive to plants in the Asteraceae family, which includes ragweed, daisies and chrysanthemums, may face a greater allergy risk.
Anyone taking prescription medication should also ask about possible interactions before beginning a concentrated herbal product. Supplements can differ in strength, purity and manufacturing quality, and they are not regulated in the same manner as prescription drugs.
The submitted information suggests evaluating results after eight to 12 weeks, but the new German study lasted six weeks and reported detectable changes by the third week. Earlier supporting trials generally lasted about two months.
Those differences mean there is not yet enough evidence to define an ideal treatment period. Patients should not rely on a fixed timetable without medical supervision and objective follow-up testing.
Artichoke leaf extract also should not be presented as a cure or as a substitute for established fatty liver treatment.
Weight reduction, regular physical activity, improved blood sugar control, lower intake of refined carbohydrates and excess calories, and management of cholesterol and triglycerides remain central to reducing liver fat.
Even modest weight loss can improve liver health in many patients. The amount needed depends on the severity of the disease and the presence of inflammation or fibrosis.
Fatty liver disease rarely results from one factor, and improvement generally requires more than one intervention. Genetics, diet, alcohol use, medications, insulin resistance, sleep, physical activity and overall metabolic health can all influence its development.
The Saarland University findings suggest artichoke leaf extract may provide additional support when used alongside those broader measures. They do not establish that the supplement will reverse fatty liver disease in every patient or prevent its long-term complications.
Larger clinical trials are needed to confirm the results, compare different doses, assess safety over longer periods and determine whether improvements in imaging correspond to meaningful changes in inflammation, fibrosis and clinical outcomes.
For now, the research identifies artichoke leaf extract as a promising but still experimental nutritional intervention. Its apparent ability to reduce liver fat and volume within several weeks deserves further study, particularly among patients with obesity who are already working to improve their metabolic health.
Source: Natural News
Original article
Comments